Gammanorm (human immune globulin subcutaneous) / Octapharma  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gammanorm (human immune globulin subcutaneous) / Octapharma
NCT03939533 / 2019-002999-13: Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases

Completed
3
64
US
CUTAQUIG
Octapharma
Primary Immune Deficiency Disorder
01/22
01/22

Download Options